Immediate Impact

4 by Nobel laureates 18 from Science/Nature 73 standout
Sub-graph 1 of 19

Citing Papers

Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
2025 Standout
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
10 intermediate papers

Works of Michael Bilous being referenced

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
2018 Standout
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
2018 Standout
and 4 more

Author Peers

Author Last Decade Papers Cites
Michael Bilous 6187 3898 2916 70 9.1k
Patrick L. Fitzgibbons 7953 5974 2919 89 13.4k
Holger Eidtmann 6429 4946 1675 123 8.5k
Nicolai J. Birkbak 2743 2580 1261 65 6.8k
Sheila E. Taube 4418 3411 883 38 8.8k
Robert L. Camp 5603 2390 1222 115 12.6k
Daniel J. Booser 5100 3389 1017 104 7.9k
Johannes L. Peterse 4817 4692 1259 97 9.8k
Gottfried E. Konecny 4561 3076 1284 148 7.4k
Jean F. Simpson 2926 2383 1169 111 6.4k
Serban Dan Costa 4749 4135 1292 103 7.5k

All Works

Loading papers...

Rankless by CCL
2026